Cargando…

Aptamer Cell-Based Selection: Overview and Advances

Aptamers are high affinity single-stranded DNA/RNA molecules, produced by a combinatorial procedure named SELEX (Systematic Evolution of Ligands by Exponential enrichment), that are emerging as promising diagnostic and therapeutic tools. Among selection strategies, procedures using living cells as c...

Descripción completa

Detalles Bibliográficos
Autores principales: Catuogno, Silvia, Esposito, Carla Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618307/
https://www.ncbi.nlm.nih.gov/pubmed/28805744
http://dx.doi.org/10.3390/biomedicines5030049
_version_ 1783267156804239360
author Catuogno, Silvia
Esposito, Carla Lucia
author_facet Catuogno, Silvia
Esposito, Carla Lucia
author_sort Catuogno, Silvia
collection PubMed
description Aptamers are high affinity single-stranded DNA/RNA molecules, produced by a combinatorial procedure named SELEX (Systematic Evolution of Ligands by Exponential enrichment), that are emerging as promising diagnostic and therapeutic tools. Among selection strategies, procedures using living cells as complex targets (referred as “cell-SELEX”) have been developed as an effective mean to generate aptamers for heavily modified cell surface proteins, assuring the binding of the target in its native conformation. Here we give an up-to-date overview on cell-SELEX technology, discussing the most recent advances with a particular focus on cancer cell targeting. Examples of the different protocol applications and post-SELEX strategies will be briefly outlined.
format Online
Article
Text
id pubmed-5618307
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-56183072017-09-29 Aptamer Cell-Based Selection: Overview and Advances Catuogno, Silvia Esposito, Carla Lucia Biomedicines Review Aptamers are high affinity single-stranded DNA/RNA molecules, produced by a combinatorial procedure named SELEX (Systematic Evolution of Ligands by Exponential enrichment), that are emerging as promising diagnostic and therapeutic tools. Among selection strategies, procedures using living cells as complex targets (referred as “cell-SELEX”) have been developed as an effective mean to generate aptamers for heavily modified cell surface proteins, assuring the binding of the target in its native conformation. Here we give an up-to-date overview on cell-SELEX technology, discussing the most recent advances with a particular focus on cancer cell targeting. Examples of the different protocol applications and post-SELEX strategies will be briefly outlined. MDPI 2017-08-14 /pmc/articles/PMC5618307/ /pubmed/28805744 http://dx.doi.org/10.3390/biomedicines5030049 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Catuogno, Silvia
Esposito, Carla Lucia
Aptamer Cell-Based Selection: Overview and Advances
title Aptamer Cell-Based Selection: Overview and Advances
title_full Aptamer Cell-Based Selection: Overview and Advances
title_fullStr Aptamer Cell-Based Selection: Overview and Advances
title_full_unstemmed Aptamer Cell-Based Selection: Overview and Advances
title_short Aptamer Cell-Based Selection: Overview and Advances
title_sort aptamer cell-based selection: overview and advances
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618307/
https://www.ncbi.nlm.nih.gov/pubmed/28805744
http://dx.doi.org/10.3390/biomedicines5030049
work_keys_str_mv AT catuognosilvia aptamercellbasedselectionoverviewandadvances
AT espositocarlalucia aptamercellbasedselectionoverviewandadvances